Walleye Trading

Walleye Trading’s Profound Medical PROF Stock Holding History

Walleye Trading’s Portfolio PROF Stock Details PROF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-10,875	Closed	-$192K	–	4866
2020 Q3	$192K	Buy	+10,875	New	+$173K	﹤0.01%	3021

Other funds holding PROF

Fidelity International

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Blackcrane Capital Bellevue, Washington $16.3M AUM 19.53% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return

Walleye Trading's PROF Position: Q4 2020 in Review

Walleye Trading sold out of Profound Medical (PROF) in Q4 2020, closing a stake of 10,875 shares — an estimated $192K sold.

Walleye Trading first reported a position in PROF in Q3 2020 and held it in 1 quarter. The position peaked at $192K in Q3 2020. 56 funds tracked by Wall St. Rank hold PROF as of Q4 2020.

Walleye Trading reported no remaining Profound Medical position as of Q4 2020 after selling out during the quarter.
Walleye Trading sold 10,875 Profound Medical shares in Q4 2020, an estimated $192K.
Walleye Trading first reported a position in Profound Medical in Q3 2020 and held it in 1 quarter.
Walleye Trading's Profound Medical position peaked at $192K in Q3 2020.
56 funds tracked by Wall St. Rank held Profound Medical as of Q4 2020.

Based on Walleye Trading's 13F filing for Q4 2020, filed 16 Feb 2021.